Bluejay Diagnostics Inc (BJDX)

$1.16 -0.05 (-4.13%)
Market Cap 1.50M
Revenue (ttm) 0.00
Net Income (ttm) -6.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,033,534
Avg Vol 4,935,140
Day's Range N/A - N/A
Shares Out 1.04M
Stochastic %K 2%
Beta 0.88
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
Tony2341
Tony2341 Jul. 21 at 7:07 PM
$BJDX The shorts here totally won. Let's be honest. Congratulations to them.
1 · Reply
kingitalia
kingitalia Jul. 21 at 6:58 PM
$BJDX fuck
0 · Reply
AtariLynx
AtariLynx Jul. 21 at 5:08 PM
$BJDX
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 4:32 PM
$BJDX squeeze this m’fer! 💪🔥👀
0 · Reply
Olivia_Strickland
Olivia_Strickland Jul. 21 at 2:36 PM
$BJDX After two weeks of no shares to short there has been almost 100k shares to short for a few days now. Shorts seem to have won this battle. Borrow rates are dropping, though still over 600, but still down from the peak of 900.
0 · Reply
dogood
dogood Jul. 21 at 2:27 PM
$BJDX can you run brother
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 2:16 PM
$BJDX let’s go bulls, red to green move 💪
0 · Reply
Sdog999
Sdog999 Jul. 21 at 2:11 PM
$BJDX bought more at 1.13
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 2:01 PM
$BJDX on watch for a bounce 👀
0 · Reply
BillyRayValentine415
BillyRayValentine415 Jul. 21 at 1:32 PM
$BJDX trash I’m out
0 · Reply
Latest News on BJDX
Bluejay Diagnostics completes enrollment in SYMON-II study

2026-07-21T10:35:18.000Z - 9 hours ago

Bluejay Diagnostics completes enrollment in SYMON-II study

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Jul 21, 2026, 6:30 AM EDT - 10 hours ago

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

2026-06-17T21:25:09.000Z - 4 weeks ago

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jun 5, 2026, 8:13 PM EDT - 6 weeks ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Jun 2, 2026, 12:19 PM EDT - 7 weeks ago

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

2026-06-02T13:13:16.000Z - 7 weeks ago

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership

2026-06-02T10:45:59.000Z - 7 weeks ago

Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Jun 2, 2026, 6:30 AM EDT - 7 weeks ago

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

May 7, 2026, 4:01 PM EDT - 2 months ago

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

2026-04-07T10:45:34.000Z - 3 months ago

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Apr 7, 2026, 6:30 AM EDT - 3 months ago

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Mar 12, 2026, 6:30 AM EDT - 4 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

2026-03-11T13:35:11.000Z - 4 months ago

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Mar 11, 2026, 9:29 AM EDT - 4 months ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

2026-03-06T11:41:51.000Z - 4 months ago

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Feb 20, 2026, 6:30 AM EST - 5 months ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Bluejay Diagnostics enrolls 545 patients in SYMON II study

2026-02-17T11:45:15.000Z - 5 months ago

Bluejay Diagnostics enrolls 545 patients in SYMON II study

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Feb 17, 2026, 6:30 AM EST - 5 months ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Bluejay Diagnostics Inc trading halted, news pending

2026-01-29T00:50:10.000Z - 6 months ago

Bluejay Diagnostics Inc trading halted, news pending

Bluejay Diagnostics announces 1-for-4 reverse stock split

2026-01-27T13:10:41.000Z - 6 months ago

Bluejay Diagnostics announces 1-for-4 reverse stock split

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

2025-12-29T12:05:14.000Z - 7 months ago

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Dec 29, 2025, 7:00 AM EST - 7 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Bluejay Diagnostics provides Q3 corporate update

2025-11-10T12:55:58.000Z - 9 months ago

Bluejay Diagnostics provides Q3 corporate update

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

2025-10-23T21:05:24.000Z - 9 months ago

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 10, 2025, 5:16 PM EDT - 10 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

2025-10-09T19:20:15.000Z - 10 months ago

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 3:15 PM EDT - 10 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

2025-10-09T12:11:30.000Z - 10 months ago

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

2025-10-09T10:35:27.000Z - 10 months ago

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Oct 9, 2025, 6:30 AM EDT - 10 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 1 year ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics provides corporate update, reduces headcount to five

2025-06-03T20:20:12.000Z - 1 year ago

Bluejay Diagnostics provides corporate update, reduces headcount to five

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 1 year ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

2025-04-29T21:35:15.000Z - 1 year ago

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting

2025-04-15T11:11:20.000Z - 1 year ago

Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 2 years ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 2 years ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Tony2341
Tony2341 Jul. 21 at 7:07 PM
$BJDX The shorts here totally won. Let's be honest. Congratulations to them.
1 · Reply
kingitalia
kingitalia Jul. 21 at 6:58 PM
$BJDX fuck
0 · Reply
AtariLynx
AtariLynx Jul. 21 at 5:08 PM
$BJDX
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 4:32 PM
$BJDX squeeze this m’fer! 💪🔥👀
0 · Reply
Olivia_Strickland
Olivia_Strickland Jul. 21 at 2:36 PM
$BJDX After two weeks of no shares to short there has been almost 100k shares to short for a few days now. Shorts seem to have won this battle. Borrow rates are dropping, though still over 600, but still down from the peak of 900.
0 · Reply
dogood
dogood Jul. 21 at 2:27 PM
$BJDX can you run brother
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 2:16 PM
$BJDX let’s go bulls, red to green move 💪
0 · Reply
Sdog999
Sdog999 Jul. 21 at 2:11 PM
$BJDX bought more at 1.13
0 · Reply
nightstocker15
nightstocker15 Jul. 21 at 2:01 PM
$BJDX on watch for a bounce 👀
0 · Reply
BillyRayValentine415
BillyRayValentine415 Jul. 21 at 1:32 PM
$BJDX trash I’m out
0 · Reply
dogood
dogood Jul. 21 at 1:21 PM
$BJDX Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study MT Newswires
0 · Reply
onlyfactshere
onlyfactshere Jul. 21 at 1:20 PM
$BJDX get in early here Run later.. Entry 1.14 glta
0 · Reply
Magglo
Magglo Jul. 21 at 1:12 PM
$BJDX good news but yesterday -16 and today there don't seem to be the conditions for a recovery.....on the contrary...
1 · Reply
kingitalia
kingitalia Jul. 21 at 1:11 PM
$BJDX shitshow
0 · Reply
kingitalia
kingitalia Jul. 21 at 12:35 PM
$BJDX good news but stock price go down...🥴
1 · Reply
AtariLynx
AtariLynx Jul. 21 at 11:06 AM
$BJDX that’s a good news!
0 · Reply
Bjmycin
Bjmycin Jul. 21 at 10:53 AM
$BJDX wow insiders buying🏄🏼‍♂️💰💰💵
0 · Reply
AtariLynx
AtariLynx Jul. 21 at 5:54 AM
$BJDX bad day for a lot of stocks. “The sleeping giants” Lipocine has dropped to 2.15; Lantern Pharma from 4.20 to 2.9 in few days… without news those kind of stocks are moved by the pumping of the moment.
0 · Reply
Olivia_Strickland
Olivia_Strickland Jul. 21 at 2:22 AM
$BJDX losing over 20% in one day (including overnight) is really not good. But for some reason people think this stock should be at 1.60 or higher. HMM
0 · Reply
BillyRayValentine415
BillyRayValentine415 Jul. 20 at 9:07 PM
$BJDX shit that close was gross
0 · Reply
BillyRayValentine415
BillyRayValentine415 Jul. 20 at 7:07 PM
$BJDX i should have dca'd this morning but technically until we cross up the 9 ema you can dca everyday. i really dont like adding to speculative position until i see some confirmation tho
0 · Reply
dogood
dogood Jul. 20 at 5:29 PM
$LIMN go green $BJDX and run $TOVX
0 · Reply